Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C10H8N4O3.ClH |
| Molecular Weight | 268.656 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 1 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.NC1=NN=C(\C=C\C2=CC=C(O2)[N+]([O-])=O)C=C1
InChI
InChIKey=STWUHYFUAQKRBO-KSMVGCCESA-N
InChI=1S/C10H8N4O3.ClH/c11-9-5-2-7(12-13-9)1-3-8-4-6-10(17-8)14(15)16;/h1-6H,(H2,11,13);1H/b3-1+;
| Molecular Formula | C10H8N4O3 |
| Molecular Weight | 232.1955 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 1 |
| Optical Activity | NONE |
| Molecular Formula | ClH |
| Molecular Weight | 36.461 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
The nitrofuran derivative, nifurprazine, is a topical antibacterial agent used mainly for the treatment of animal diseases. It is a trypanocidal drug. Nifurprazine proved to be the most promising derivative since it was redox-cycled by both T. cruzi LipDH and TR and had pronounced antiparasitic effects in cultures of T. cruzi and Trypanosoma brucei.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Nitrofuran drugs as common subversive substrates of Trypanosoma cruzi lipoamide dehydrogenase and trypanothione reductase. | 1999-12-01 |
|
| [Microbiological demonstration of nifurprazine in body fluids and tissues of cattle]. | 1976-05 |
|
| [Contact allergies due to nifurprazine (Carofur)]. | 1969-08-22 |
Patents
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/10571254
At concentrations of 100 uM, nifurprazine caused a 72% inhibition of trypanothione reductase (TR) activity. At 10 uM, nifurprazine inhibited parasite growth completely, but was also toxic to the mammalian host cells. Nifurprazine (3 uM) induced a 100% growth inhibition of T. brucei.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 19:51:53 GMT 2025
by
admin
on
Mon Mar 31 19:51:53 GMT 2025
|
| Record UNII |
J20OYU9Q77
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
6438145
Created by
admin on Mon Mar 31 19:51:53 GMT 2025 , Edited by admin on Mon Mar 31 19:51:53 GMT 2025
|
PRIMARY | |||
|
m846
Created by
admin on Mon Mar 31 19:51:53 GMT 2025 , Edited by admin on Mon Mar 31 19:51:53 GMT 2025
|
PRIMARY | Merck Index | ||
|
J20OYU9Q77
Created by
admin on Mon Mar 31 19:51:53 GMT 2025 , Edited by admin on Mon Mar 31 19:51:53 GMT 2025
|
PRIMARY | |||
|
50832-74-1
Created by
admin on Mon Mar 31 19:51:53 GMT 2025 , Edited by admin on Mon Mar 31 19:51:53 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |